Skip to main content
logo
Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China flag China · Delayed Price · Currency is CNY
2.900
+0.010 (0.35%)
Jun 12, 2026, 3:04 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceutical Distribution
4.21B4.75B5.27B5.28B5.36B
Pharmaceutical Distribution Growth
-11.20%-10.03%-0.10%-1.53%10.44%
Medical Services
1.57B1.64B1.79B1.86B2.07B
Medical Services Growth
-3.75%-8.48%-3.90%-10.18%5.24%
Pharmaceutical Manufacturing
1.01B938.69M843.52M790.26M704.12M
Pharmaceutical Manufacturing Growth
7.64%11.28%6.74%12.23%16.05%
Other Industries
2.00M2.09M2.30M8.61M14.29M
Other Industries Growth
-4.07%-9.30%-73.25%-39.77%-21.29%
Consolidated Offset
-1.18B-1.29B-1.45B-1.59B-1.68B
Total
5.62B6.03B6.46B6.35B6.47B
Total Growth
-6.84%-6.63%1.75%-1.88%10.71%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Northeast
10.95M15.64M23.28M24.46M30.22M
Northeast Growth
-30.00%-32.83%-4.83%-19.05%34.93%
North China
63.33M78.73M94.84M104.62M112.57M
North China Growth
-19.56%-16.99%-9.35%-7.06%25.34%
East China
811.99M730.94M606.83M529.11M398.71M
East China Growth
11.09%20.45%14.69%32.71%37.62%
South China
9.89M12.22M11.84M14.72M12.43M
South China Growth
-19.02%3.20%-19.59%18.40%-63.83%
Central China
35.28M39.44M39.91M39.66M48.53M
Central China Growth
-10.54%-1.18%0.61%-18.27%14.36%
Northwest
5.12M6.05M7.06M10.99M12.13M
Northwest Growth
-15.36%-14.24%-35.79%-9.39%5.13%
Southwest
5.86B6.44B7.12B7.22B7.54B
Southwest Growth
-8.93%-9.61%-1.27%-4.27%8.90%
Consolidated Offset
-1.18B-1.29B-1.45B-1.59B-1.68B
Total
5.62B6.03B6.46B6.35B6.47B
Total Growth
-6.84%-6.63%1.75%-1.88%10.71%